Mindfulness Practices for ADHD
Trial Summary
The trial does not specify if you need to stop your current medications, but it mentions that participants should not have an unstable dosage of psychotropic medication (medications that affect mood, perception, or behavior). It might be best to discuss your current medication with the trial coordinators.
Research shows that mindfulness-based treatments, like Mindfulness-Based Cognitive Therapy (MBCT) and Mindful Awareness Practices (MAPs), can help reduce ADHD symptoms and improve mental health in adults. These therapies have shown promising results in improving attention and self-control, which are often challenging for people with ADHD.
12345Mindfulness practices, like Mindfulness-Based Cognitive Therapy (MBCT) and Mindful Awareness Practices (MAPs), have been studied for ADHD and are generally considered safe for adults and children. Some studies show they can help improve mental health and reduce ADHD symptoms, with only a modest drop-out rate, indicating they are well-tolerated.
34567Mindfulness Awareness Practices for ADHD is unique because it focuses on improving attention and self-regulation through mindfulness meditation, which is a non-drug approach. This treatment helps individuals with ADHD by enhancing their ability to focus and manage emotions, offering an alternative or complement to traditional medication-based therapies.
34589Eligibility Criteria
This trial is for first-year college students aged 17-25 who have been diagnosed with ADHD. Participants should not have major medical issues or severe mental health conditions like depression, mania, substance abuse, personality disorders that could affect group participation, psychosis, recent trauma, or unstable psychotropic medication doses.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo an 8-week, group-based mindfulness program (MAPs) for ADHD, delivered within university counseling center settings.
Follow-up
Participants are monitored for safety and effectiveness after treatment, with assessments at 1-month and 6-month post-treatment.